Cited by 1,745Immune responses and vaccinationsT-cell and B-cell ImmunologyImmunotherapy and Immune Responses

The DOI matches its Crossref record; 204 of the 204 references it cites were found in a registry or an index.

Correlates of Protection Induced by Vaccination

Open access

Plotkin, Stanley A.·2010·Clinical and Vaccine Immunology

Open this paper in CoChat — free account

Abstract

This paper attempts to summarize current knowledge about immune responses to vaccines that correlate with protection. Although the immune system is redundant, almost all current vaccines work through antibodies in serum or on mucosa that block infection or bacteremia/viremia and thus provide a correlate of protection. The functional characteristics of antibodies, as well as quantity, are important. Antibody may be highly correlated with protection or synergistic with other functions. Immune memory is a critical correlate: effector memory for short-incubation diseases and central memory for long-incubation diseases. Cellular immunity acts to kill or suppress intracellular pathogens and may also synergize with antibody. For some vaccines, we have no true correlates, but only useful surrogates, for an unknown protective response.

Integrity signals

Registry

Crossref · 10.1128/cvi.00131-10

Cites

204 of 204 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults
Oxman, M. N., Levin, M. J., Johnson, G. R., Schmader, K. E., Straus, S. E., Gelb, L. D., Arbeit, R. D., Simberkoff, M. S., Gershon, A. A., Davis, L. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051016 · Cited by 2,412
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
The FUTURE II Study Group (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061741 · Cited by 2,079
Viral Hepatitis and Liver Disease
Vyas, G. N., Dienstag, J. L., & Hoofnagle, J. H. (1985) · Medical Entomology and Zoology · Cited by 1,867
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomised study in young women
Paavonen, J., Naud, P., Salmerón, J., Wheeler, C., Chow, S.-N., Apter, D., Kitchener, H., Castellsague, X., Teixeira, J., Skinner, Sr., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61248-4 · Cited by 1,655
Pathogenesis of Dengue: Challenges to Molecular Biology
Halstead, S. B. (1988) · Science · doi:10.1126/science.3277268 · Cited by 1,612
IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge
Khader, S. A., Bell, G. K., Pearl, J. E., Fountain, J. J., Rangel‐Moreno, J., Cilley, G. E., Shen, F., Eaton, S. M., Gaffen, S. L., Swain, S. L., et al. (2007) · Nature Immunology · doi:10.1038/ni1449 · Cited by 1,470
Research on Dengue during World War II
Sabin, A. B. (1952) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1952.1.30 · Cited by 955
Duration of antiviral immunity after smallpox vaccination
Hammarlund, E., Lewis, M. W., Hansen, S. G., Strelow, L. I., Nelson, J. A., Sexton, G. J., Hanifin, J. M., & Slifka, M. K. (2003) · Nature Medicine · doi:10.1038/nm917 · Cited by 946
Vaccines: Correlates of Vaccine‐Induced Immunity
Plotkin, S. A. (2008) · Clinical Infectious Diseases · doi:10.1086/589862 · Cited by 829
Self-citation
Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas.
Suzich, J., Ghim, S., Palmer‐Hill, F. J., et al. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11553 · Cited by 676
Measles Antibody: Reevaluation of Protective Titers
Chen, R. T., Markowitz, L. E., Albrecht, P. G., Stewart, J. A., MOFENSON, L. M., Preblud, S. R., & Orenstein, W. A. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/162.5.1036 · Cited by 606
Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection
Breitburd, F., Kirnbauer, R., Hubbert, N. L., et al. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3959-3963.1995 · Cited by 595
T Cell Responses Are Better Correlates of Vaccine Protection in the Elderly
McElhaney, J. E., Xie, D., Hager, W. D., Barry, M. B., Wang, Y., Kleppinger, A., Ewen, C., Kane, K. P., & Bleackley, R. C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.6333 · Cited by 561
Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity
Querec, T. D., Bennouna, S., Alkan, S., Laouar, Y., Gorden, K. B., Flavell, R. A., Akira, S., Ahmed, R., & Pulendran, B. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051720 · Cited by 557
The Protective Level of Serum Antibodies to the Capsular Polysaccharide of Haemophilus influenzae Type b
Kayhty, R., Peltola, H., Karanko, V., & Makela, P. H. (1983) · The Journal of Infectious Diseases · doi:10.1093/infdis/147.6.1100 · Cited by 543
Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis
Storsæter, J., Hallander, H. O., Gustafsson, L., & Olin, P. (1998) · Vaccine · doi:10.1016/s0264-410x(98)00227-8 · Cited by 493
Cell-mediated Protection in Influenza Infection
Thomas, P. G., Keating, R., Hulse-Post, D. J., & Doherty, P. C. (2006) · Emerging infectious diseases · doi:10.3201/eid1201.051237 · Cited by 466
A controlled clinical trial of the efficacy of the hepatitis B vaccine (heptavax B): A final report
Szmuness, W., Stevens, C. E., Zang, E. A., et al. (1981) · Hepatology · doi:10.1002/hep.1840010502 · Cited by 466
Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice
Zhang, Z., Clarke, T. B., & Weiser, J. N. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36731 · Cited by 453
The Prevention of Hepatitis B with Vaccine
Francis, D. P., HADLER, S. C., THOMPSON, S. E., et al. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-3-362 · Cited by 440
A search for serologic correlates of immunity to Bordetella pertussis cough illnesses
Cherry, J. D., GORNBEIN, J. A., Heininger, U., & STEHR, K. (1998) · Vaccine · doi:10.1016/s0264-410x(98)00226-6 · Cited by 434
Correlates of Immune Protection Induced by Live, Attenuated, Cold‐Adapted, Trivalent, Intranasal Influenza Virus Vaccine
Belshe, R. B., Gruber, W. C., Mendelman, P. M., Mehta, H. B., Mahmood, K., Reisinger, K. S., Treanor, J. J., Zangwill, K., Hayden, F. G., Bernstein, D. I., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315323 · Cited by 419
Meningococcal surrogates of protection?serum bactericidal antibody activity
Borrow, R., Balmer, P., & Miller, E. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.051 · Cited by 414
Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification
Balsitis, S. J., Williams, K. L., Lachica, R., Flores, D., Kyle, J. L., Mehlhop, E., Johnson, S., Diamond, M., Beatty, P. R., & Harris, E. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000790 · Cited by 412
Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals
Goronzy, J. J., Fulbright, J. W., Crowson, C. S., Poland, G. A., O'Fallon, W. M., & Weyand, C. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.24.12182-12187.2001 · Cited by 402
Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants
Jódar, L., Butler, J. C., Carlone, G. M., Dagan, R., Goldblatt, D., Käyhty, H. M., Klugman, K. P., Plikaytis, B. D., Siber, G. R., Kohberger, R. C., et al. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00230-5 · Cited by 387
Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination
West, D. (1996) · Vaccine · doi:10.1016/0264-410x(96)00062-x · Cited by 379
Varicella in Children With Cancer: Seventy-Seven Cases
Feldman, S., Hughes, W. T., & Daniel, C. B. (1976) · PEDIATRICS · doi:10.1542/peds.57.2.196 · Cited by 370
Varicella in Children With Cancer: Seventy-Seven Case
Feldman, S., Hughes, W. T., & Daniel, C. B. (1975) · PEDIATRICS · doi:10.1542/peds.56.3.388 · Cited by 370
Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies
Siber, G. R., Chang, I., Baker, S. A., Fernsten, P. D., O’Brien, K. L., Santosham, M., Klugman, K. P., Madhi, S. A., Paradiso, P. R., & Kohberger, R. C. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.119 · Cited by 365
Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18
Pastrana, D. V., Buck, C. B., Pang, Y.-Y. S., Thompson, C. D., Castle, P. E., FitzGerald, P. C., Kjær, S. K., Lowy, D. R., & Schiller, J. T. (2004) · Virology · doi:10.1016/j.virol.2003.12.027 · Cited by 358
Varicella‐Zoster Virus–Specific Immune Responses in Elderly Recipients of a Herpes Zoster Vaccine
Levin, M. J., Oxman, M. N., Zhang, J. H., Johnson, G. R., Stanley, H., Hayward, A. R., Caulfield, M. J., Irwin, M. R., Smith, J. G., Clair, J. S., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/528696 · Cited by 355
What Level of Hepatitis B Antibody Is Protective?
Jack, A. D., Hall, A. J., Maine, N., Mendy, M. E., & Whittle, H. C. (1999) · The Journal of Infectious Diseases · doi:10.1086/314578 · Cited by 353
Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6·4 years
‡ (2009) · The Lancet · doi:10.1016/s0140-6736(09)61567-1 · Cited by 352
Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age
Peltola, H., Mäkelä, P. H., Käyhty, H. M., Jousimies, H., Herva, E., Hällström, K., Sivonen, A., Renkonen, O.-V., PETTAY, O., Karanko, V., et al. (1977) · New England Journal of Medicine · doi:10.1056/nejm197709292971302 · Cited by 345
The size of the viral inoculum contributes to the outcome of hepatitis B virus infection
Asabe, S., Wieland, S. F., Chattopadhyay, P. K., Roederer, M., Engle, R. E., Purcell, R. H., & Chisari, F. V. (2009) · Journal of Virology · doi:10.1128/jvi.00867-09 · Cited by 320
Reduction in Functional Antibody Activity Against Streptococcus pneumoniae in Vaccinated Elderly Individuals Highly Correlates with Decreased IgG Antibody Avidity
Romero‐Steiner, S., Musher, D. M., Cetron, M. S., Pais, L. B., Groover, J. E., & Carlone, G. M. (1999) · Clinical Infectious Diseases · doi:10.1086/520200 · Cited by 311
Quantitative Measurement of “Natural” and Immunization-induced Haemophilus influenzas type b Capsular Polysaccharide Antibodies
Robbins, J. B., Parke, J. C., Schneerson, R., et al. (1973) · Pediatric Research · doi:10.1203/00006450-197303000-00001 · Cited by 291
Varicella‐Zoster Virus–Specific Immune Responses to Herpes Zoster in Elderly Participants in a Trial of a Clinically Effective Zoster Vaccine
Weinberg, A., Zhang, J. H., Oxman, M. N., Johnson, G. R., Hayward, A. R., Caulfield, M. J., Irwin, M. R., Clair, J. S., Smith, J. G., Stanley, H. A., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/605611 · Cited by 271
The Immune Response to Pneumococcal Proteins during Experimental Human Carriage
McCool, T. L., Cate, T. R., Moy, G., & Weiser, J. N. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011576 · Cited by 270
Immunity and correlates of protection for rotavirus vaccines
Franco, M. A., Angel, J., & Greenberg, H. B. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.12.048 · Cited by 268
Distribution of Poliovirus Antibody in Serum, Nasopharynx and Alimentary Tract Following Segmental Immunization of Lower Alimentary Tract with Poliovaccine
Ogra, P. L. O., & Karzon, D. T. (1969) · The Journal of Immunology · doi:10.4049/jimmunol.102.6.1423 · Cited by 266
In vitro correlate of immunity in a rabbit model of inhalational anthrax
Pitt, M. L. M., Little, S. F., Ivins, B. E., et al. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00234-1 · Cited by 264
Chapter 12: Prophylactic HPV vaccines: Underlying mechanisms
Stanley, M., Lowy, D. R., & Frazer, I. H. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.110 · Cited by 262
Correlation of Cellular Immune Responses with Protection against Culture-Confirmed Influenza Virus in Young Children
Forrest, B. D., Pride, M. W., Dunning, A. J., Capeding, M. R., Chotpitayasunondh, T., Tam, J. S. L., Rappaport, R., Eldridge, J. H., & Gruber, W. C. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00397-07 · Cited by 260
Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell–mediated immunity
Liu, L., Zhong, Q., Tian, T., Dubin, K. A., Athale, S., & Kupper, T. S. (2010) · Nature Medicine · doi:10.1038/nm.2078 · Cited by 257
Mucosal Immunity Induced by Enhanced-Potency Inactivated and Oral Polio Vaccines
Onorato, I. M., Modlin, J. F., McBean, A. M., THOMS, M. L., Losonsky, G. A., & Bernier, R. H. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/163.1.1 · Cited by 246
Immunologic correlates of protection induced by vaccination
Plotkin, S. A. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200101000-00013 · Cited by 242
Self-citation
Immunity and immunological memory following smallpox vaccination
Amanna, I. J., Slifka, M. K., & Crotty, S. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00392.x · Cited by 233
Search for Correlates of Protective Immunity Conferred by Anthrax Vaccine
Reuveny, S., White, M. D., Adar, Y., et al. (2001) · Infection and Immunity · doi:10.1128/iai.69.5.2888-2893.2001 · Cited by 231
Polysaccharide Vaccines of Group A Neisseria meningitidis and Haemophilus influenzae Type b: A Field Trial in Finland
Mäkelä, P. H., Peltola, H., Käyhty, H. M., et al. (1977) · The Journal of Infectious Diseases · doi:10.1093/infdis/136.supplement.s43 · Cited by 230
Re: Specific Antibody Levels at the Cervix During the Menstrual Cycle of Women Vaccinated With Human Papillomavirus 16 Virus-Like Particles
Barr, E., & Koutsky, L. A. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh071 · Cited by 230
Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine
Clements, M. L., & Murphy, B. R. (1986) · Journal of Clinical Microbiology · doi:10.1128/jcm.23.1.66-72.1986 · Cited by 229
Systematic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease
Yuan, L., Ward, L., Rosen, B. I., To, T. L., & Saif, L. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.5.3075-3083.1996 · Cited by 226
Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults
McElhaney, J. E., Ewen, C., Zhou, X., Kane, K. P., Xie, D., Hager, W. D., Barry, M. B., Kleppinger, A., Wang, Y., & Bleackley, R. C. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.136 · Cited by 219
CD4 + T-Cell Responses Are Required for Clearance of West Nile Virus from the Central Nervous System
Sitati, E. M., & Diamond, M. (2006) · Journal of Virology · doi:10.1128/jvi.01650-06 · Cited by 214
Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2–3 September, 2004
Hombach, J., Solomon, T., Kurane, I., et al. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.07.002 · Cited by 212
The Role of Serum Antibodies in the Protection against Rotavirus Disease: An Overview
Jiang, B., Gentsch, J. R., & Glass, R. I. (2002) · Clinical Infectious Diseases · doi:10.1086/340103 · Cited by 209
Specific Antibody Levels at the Cervix During the Menstrual Cycle of Women Vaccinated With Human Papillomavirus 16 Virus-Like Particles
Nardelli‐Haefliger, D., Wirthner, D., Schiller, J. T., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg018 · Cited by 207
HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine
Joura, E. A., Kjær, S. K., Wheeler, C. M., Sigurðsson, K., Iversen, O., Hernández‐Ávila, M., Pérez, G., Brown, D. R., Koutsky, L. A., Tay, E. H., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.09.073 · Cited by 201
Mechanisms of Immune Evasion Induced by a Complex of Dengue Virus and Preexisting Enhancing Antibodies
Ubol, S., Phuklia, W., Kalayanarooj, S., & Modhiran, N. (2010) · The Journal of Infectious Diseases · doi:10.1086/651018 · Cited by 200
Correlation between Pertussis Toxin IgG Antibodies in Postvaccination Sera and Subsequent Protection against Pertussis
TARANGER, J., Trollfors, B., Lagergård, T., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315318 · Cited by 195
Role of virus strain dm conventional and enhanced measles plaque neutralization test
Albrecht, P. G., Herrmann, K. L., & Burns, G. R. (1981) · Journal of Virological Methods · doi:10.1016/0166-0934(81)90062-8 · Cited by 191
The role of secondary vaccine failures in measles outbreaks.
Mathias, R., Meekison, W., Arcand, T. A., et al. (1989) · American Journal of Public Health · doi:10.2105/ajph.79.4.475 · Cited by 185
Modified cases of chickenpox after varicella vaccination
White, C. J., Kuter, B. J., Ngai, A. L., et al. (1992) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199201000-00006 · Cited by 182
Rubella Immunity:Defining the Level of Protective Antibody
Skendzel, L. P. (1996) · American Journal of Clinical Pathology · doi:10.1093/ajcp/106.2.170 · Cited by 180
Comparative Evaluation of Immunization with Live Attenuated and Enhanced-Potency Inactivated Trivalent Poliovirus Vaccines in Childhood: Systemic and Local Immune Responses
Faden, H. S., Modlin, J. F., THOMS, M. L., McBean, A. M., Ferdon, M. B., & Ogra, P. L. O. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/162.6.1291 · Cited by 178
Cellular Immune Responses to Human Papillomavirus (HPV)–16 L1 in Healthy Volunteers Immunized with Recombinant HPV‐16 L1 Virus‐Like Particles
Pinto, L. A., Edwards, J., Castle, P. E., Harro, C. D., Lowy, D. R., Schiller, J. T., Wallace, D., Kopp, W., Adelsberger, J. W., Baseler, M., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/376505 · Cited by 177
Antibody Response in Serum and Nasopharynx after Naturally Acquired and Vaccine-Induced Infection with Rubella Virus
Ogra, P. L. O., Kerr-Grant, D., Umana, G., et al. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112092852401 · Cited by 174
Estimating Haemophilus influenzae Type b Vaccine Effectiveness in England and Wales by Use of the Screening Method
Ramsay, M. E., McVernon, J., Andrews, N. J., Heath, P. T., & Slack, M. P. (2003) · The Journal of Infectious Diseases · doi:10.1086/376997 · Cited by 172
The protective role of antibody responses duringMycobacterium tuberculosisinfection
Abebe, F., & Bjune, G. A. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.03967.x · Cited by 171
Persistence of Immunity to Varicella in Children with Leukemia Immunized with Live Attenuated Varicella Vaccine
Gershon, A. A., & Steinberg, S. P. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201403 · Cited by 167
Protective Effects of Towne Cytomegalovirus Vaccine Against Low-Passage Cytomegalovirus Administered as a Challenge
Plotkin, S. A., Starr, S. E., Friedman, H. M., et al. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/159.5.860 · Cited by 167
Self-citation
Mumps Outbreaks in Vaccinated Populations: Are Available Mumps Vaccines Effective Enough to Prevent Outbreaks?
Dayan, G. H., & Rubin, S. A. (2008) · Clinical Infectious Diseases · doi:10.1086/591196 · Cited by 167
Yellow Fever Vaccine: Direct Challenge of Monkeys Given Graded Doses of 17D Vaccine
Mason, R. A., Tauraso, N. M., Spertzel, R. O., & Ginn, R. K. (1973) · Applied Microbiology · doi:10.1128/am.25.4.539-544.1973 · Cited by 165
Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine
Little, S. F., Ivins, B. E., Fellows, P. F., et al. (2003) · Vaccine · doi:10.1016/j.vaccine.2003.07.004 · Cited by 165
A Prospective Study of Serum Antibody and Protection Against Smallpox
Mack, T. M., Noble, J., & Thomas, D. B. (1972) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1972.21.214 · Cited by 160
Serum Serotype‐Specific Pneumococcal Anticapsular Immunoglobulin G Concentrations after Immunization with a 9‐Valent Conjugate Pneumococcal Vaccine Correlate with Nasopharyngeal Acquisition of Pneumococcus
Dagan, R., Givon‐Lavi, N., Fraser, D., Lipsitch, M., Siber, G. R., & Kohberger, R. C. (2005) · The Journal of Infectious Diseases · doi:10.1086/431679 · Cited by 153
Mumps resurgences in the United States: A historical perspective on unexpected elements
Barskey, A. E., Glasser, J. W., & LeBaron, C. W. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.109 · Cited by 151
Circulating Antitoxin at the Onset of Diphtheria in 425 Patients
Ipsen, J. (1946) · The Journal of Immunology · doi:10.4049/jimmunol.54.4.325 · Cited by 149
Untitled work
(2007) · PubMed · Cited by 142
A Long-term Prospective Study of Varicella Vaccine in Healthy Children
Johnson, C. E., Stancin, T., Fattlar, D., et al. (1997) · PEDIATRICS · doi:10.1542/peds.100.5.761 · Cited by 141
Primary Vaccine Failure after 1 Dose of Varicella Vaccine in Healthy Children
Michalik, D. E., Steinberg, S. P., LaRussa, P. S., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/529043 · Cited by 139
Inactivated poliovirus vaccine: Past and present experience
Murdin, A. D., Barreto, L., & Plotkin, S. (1996) · Vaccine · doi:10.1016/0264-410x(95)00211-i · Cited by 135
Self-citation
Antibody Induced by Immunization with the Jeryl Lynn Mumps Vaccine Strain Effectively Neutralizes a Heterologous Wild‐Type Mumps Virus Associated with a Large Outbreak
Rubin, S. A., Qi, L., Audet, S. A., Sullivan, B. J., Carbone, K. M., Bellini, W. J., Rota, P. A., Sirota, L. A., & Beeler, J. A. (2008) · The Journal of Infectious Diseases · doi:10.1086/590115 · Cited by 135
Prevention ofHaemophilus influenzaeType b Infections in High-Risk Infants Treated with Bacterial Polysaccharide Immune Globulin
Santosham, M., Reid, R., Ambrosino, D. M., Wolff, M., Almeido-Hill, J., Priehs, C., Aspery, K. M., Garrett, S., Croll, L., Foster, S. L., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198710083171503 · Cited by 133
Lymphocyte responses to varicella zoster virus in the elderly
Hayward, A. R., & Herberger, M. (1987) · Journal of Clinical Immunology · doi:10.1007/bf00916011 · Cited by 131
Serologic status and measles attack rates among vaccinated and unvaccinated children in rural Senegal
Samb, B., Aaby, P., WHITTLE, H. C., et al. (1995) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199503000-00007 · Cited by 130
Measles and Measles Immunity in Children Infected With Human Immunodeficiency Virus
Krasinski, K. M. (1989) · JAMA · doi:10.1001/jama.1989.03420170056030 · Cited by 129
Successful DNA immunization against measles: Neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles
Polack, F. P., Lee, S. H., Permar, S. R., et al. (2000) · Nature Medicine · doi:10.1038/77506 · Cited by 127
Anti-Rotavirus G Type-Specific and Isotype-Specific Antibodies in Children with Natural Rotavirus Infections
O’Ryan, M. L., Matson, D. O., Estes, M. K., & Pickering, L. K. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.3.504 · Cited by 127
Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis
Storsæter, J., Hallander, H. O., Gustafsson, L., et al. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00407-9 · Cited by 126
Twelve-year follow-up study of hepatitis B immunization of Senegalese infants
Coursaget, P., Leboulleux, D., SOUMARÉ, M., et al. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80404-0 · Cited by 126
Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection
Li, S., CHAN, A. S. F., Matthews, H., et al. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200204000-00014 · Cited by 125
Pathogenesis of Rabies
Dietzschold, B., Schnell, M. J., & Koprowski, H. (2005) · Springer eBooks · doi:10.1007/3-540-27485-5_3 · Cited by 125
Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children
Liao, S., Li, R., Li, H., et al. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00031-6 · Cited by 124
Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice
Shresta, S., Kyle, J. L., Beatty, P. R., et al. (2004) · Virology · doi:10.1016/j.virol.2003.09.048 · Cited by 119
Protective Immunity against Secondary Poxvirus Infection Is Dependent on Antibody but Not on CD4 or CD8 T-Cell Function
Panchanathan, V., Chaudhri, G., & Karupiah, G. (2006) · Journal of Virology · doi:10.1128/jvi.00115-06 · Cited by 118
Viremia, Virus Excretion, and Antibody Responses after Challenge in Volunteers with Low Levels of Antibody to Rubella Virus
O'Shea, S., Best, J. M., & Banatvala, J. E. (1983) · The Journal of Infectious Diseases · doi:10.1093/infdis/148.4.639 · Cited by 117
The Prophylactic Dose of Homologous Tetanus Antitoxin
McComb, J. A. (1964) · New England Journal of Medicine · doi:10.1056/nejm196401232700404 · Cited by 116
Role of CD8+Lymphocytes in Control and Clearance of Measles Virus Infection of Rhesus Monkeys
Permar, S. R., Klumpp, S. A., Mansfield, K. G., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.7.4396-4400.2003 · Cited by 113
Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype
Nöjd, J., Tecle, T., Samuelsson, A., et al. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00392-3 · Cited by 112
Redundancy and Plasticity of Neutralizing Antibody Responses Are Cornerstone Attributes of the Human Immune Response to the Smallpox Vaccine
Benhnia, M. R., McCausland, M. M., Su, H.-P., Singh, K., Hoffmann, J., Davies, D. H., Felgner, P. L., Head, S. R., Sette, A., Garboczi, D. N., et al. (2008) · Journal of Virology · doi:10.1128/jvi.02244-07 · Cited by 111
Duration of Immunity After Hepatitis B Vaccination: Efficacy of Low-Dose Booster Vaccine
Horowitz, M. M., ERSHLER, W. B., McKinney, W. P., et al. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-2-185 · Cited by 109
Development of a rotavirus vaccine: Clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq®
Ciarlet, M., & Schödel, F. P. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.09.107 · Cited by 108
The Immune Response to BCG Vaccination of Newborns
Hanekom, W. A. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1358.010 · Cited by 106
Long-term presence of memory B-cells specific for different vaccine components
Buisman, A., de Rond, C. G. H., Öztürk, K., ten Hulscher, H. I., & van Binnendijk, R. S. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.09.102 · Cited by 103
Rising incidence of Haemophilus influenzae type b disease in England and Wales indicates a need for a second catch-up vaccination campaign.
Trotter, C. L., Ramsay, M. E., & Slack, M. (2003) · PubMed · Cited by 101
Correlates of protective immunity in poxvirus infection: where does antibody stand?
Panchanathan, V., Chaudhri, G., & Karupiah, G. (2007) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100118 · Cited by 99
On Immunity Against Infections and Vaccines: Credo 2004
Zinkernagel, R. M. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01460.x · Cited by 97
The minimum protective level of antibodies in smallpox.
Sarkar, J., Mitra, A., & Mukherjee, M. K. (1975) · PubMed · Cited by 95
Protection of Rhesus Monkeys against Dengue Virus Challenge after Tetravalent Live Attenuated Dengue Virus Vaccination
Sun, W., Nisalak, A., Gettayacamin, M., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/503372 · Cited by 95
FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10–11, 2007
Eichelberger, M. C., Golding, H., Hess, M., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.06.012 · Cited by 93
SPECIFIC PROPHYLAXIS OF TETANUS
Edsall, G. (1959) · JAMA · doi:10.1001/jama.1959.73010220003012 · Cited by 93
Correlates of immunity for pneumococcal conjugate vaccines
Lee, L. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00025-2 · Cited by 90
Poliovirus Vaccine–Inactivated
Vidor, E. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00047-x · Cited by 89
Natural or vaccine-induced antibody as a predictor of immunity in the face of natural challenge with influenza viruses
Davies, J. R., & Grilli, E. A. (1989) · Epidemiology and Infection · doi:10.1017/s0950268800030004 · Cited by 88
Antitoxin Antibody Levels and the Outcome of Illness during an Outbreak of Diphtheria among Alcoholics
Björkholm, B., Böttiger, M., CHRISTENSON, B., et al. (1986) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548609032332 · Cited by 87
Active Immunity against Rotavirus Infection in Mice Is Correlated with Viral Replication and Titers of Serum Rotavirus IgA Following Vaccination
McNeal, M., Broome, R. L., & Ward, R. L. (1994) · Virology · doi:10.1006/viro.1994.1579 · Cited by 87
Antibody Responses in Serum and Nasal Secretions of Children Immunized with Inactivated and Attenuated Measles-Virus Vaccines
Bellanti, J. A., Sanga, R. L., Klutinis, B. S., et al. (1969) · New England Journal of Medicine · doi:10.1056/nejm196903202801202 · Cited by 87
Prevention ofHaemophilus influenzaeType b Colonization by Vaccination: Correlation with Serum Anti‐Capsular IgG Concentration
Fernández, J., Levine, O. S., Sánchez, J., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315870 · Cited by 85
Hepatitis A Vaccine
Herck, K. V., & Damme, P. V. (2004) · New England Journal of Medicine · doi:10.1056/nejm200405203502121 · Cited by 84
Serum IgG mediates mucosal immunity against rotavirus infection
Westerman, L. E., McClure, H. M., Jiang, B., Almond, J. W., & Glass, R. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502437102 · Cited by 82
Virus-specific intestinal IFN-gamma producing T cell responses induced by human rotavirus infection and vaccines are correlated with protection against rotavirus diarrhea in gnotobiotic pigs.
Yuan, L., Wen, K., Azevedo, M. S., González, A., Zhang, W., & Saif, L. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.03.085 · Cited by 81
Limited Contribution of Humoral Immunity to the Clearance of Measles Viremia in Rhesus Monkeys
Permar, S. R., Klumpp, S. A., Mansfield, K. G., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/422846 · Cited by 81
Correlates of protection: Novel generations of influenza vaccines
Rimmelzwaan, G. F., & McElhaney, J. E. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.07.043 · Cited by 78
Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates
Williamson, E. D., Flick-Smith, H. C., Waters, E. L., et al. (2006) · Microbial Pathogenesis · doi:10.1016/j.micpath.2006.09.003 · Cited by 78
Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview
Nalin, D. R., Kuter, B. J., Brown, L., PATTERSON, C. M., Calandra, G., Werzberger, A., Shouval, D., Ellerbeck, E. F., Block, S. L., Bishop, R., et al. (1993) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80379-4 · Cited by 78
Rectal Immunization with Rotavirus Virus-Like Particles Induces Systemic and Mucosal Humoral Immune Responses and Protects Mice against Rotavirus Infection
Parez, N., Fourgeux, C., Si‐Mohamed, A., et al. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.1752-1761.2006 · Cited by 78
Age-DependentNeisseria meningitidisSerogroup C Class-Specific Antibody Concentrations and Bactericidal Titers in Sera from Young Children from Montana Immunized with a Licensed Polysaccharide Vaccine
Maslanka, S. E., Tappero, J. W., Plikaytis, B. D., et al. (1998) · Infection and Immunity · doi:10.1128/iai.66.6.2453-2459.1998 · Cited by 77
Humanized Monoclonal Antibodies Derived from Chimpanzee Fabs Protect against Japanese Encephalitis Virus In Vitro and In Vivo
Goncalvez, A. P., Chien, C.-H., Tubthong, K., et al. (2008) · Journal of Virology · doi:10.1128/jvi.00291-08 · Cited by 77
Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model
Kyle, J. L., Balsitis, S. J., Zhang, L. H., Beatty, P. R., & Harris, E. (2008) · Virology · doi:10.1016/j.virol.2008.08.008 · Cited by 76
Difficulties in Establishing a Serological Correlate of Protection After Immunization with Haemophilus Influenzae Conjugate Vaccines
Käyhty, H. M. (1994) · Biologicals · doi:10.1006/biol.1994.1062 · Cited by 76
Inactivated rotavirus vaccines: A priority for accelerated vaccine development
Jiang, B., Gentsch, J. R., & Glass, R. I. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.10.008 · Cited by 76
Haemophilus influenzae Type b Vaccine Failure in Children Is Associated with Inadequate Production of High-Quality Antibody
Lee, Y. C., Kelly, D. F., Yu, L., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/524668 · Cited by 76
Correlates of Immune Protection from Tuberculosis
Fletcher, H. A. (2007) · Current Molecular Medicine · doi:10.2174/156652407780598520 · Cited by 75
LIMITATION OF FECAL AND PHAEYNGEAL POLIOVIEUSEXCRETION IN SALK-VACCINATED CHILDREN
Marine, W. M., Chin, T. D. Y., & Gravelle, C. R. (1962) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120272 · Cited by 75
Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles
Pan, C.-H., Valsamakis, A., Colella, T. A., Nair, N., Adams, R. J., Polack, F. P., Greer, C. E., Perri, S., Polo, J. M., & Griffin, D. E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504592102 · Cited by 74
Over five-year follow-up of Oka/Merck varicella vaccine recipients in 465 infants and adolescents
Clements, D. A., Armstrong, C. B., Ursano, A. M., et al. (1995) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199510000-00011 · Cited by 74
Immune correlates of protection against influenza in the human challenge model.
Treanor, J. J., & Wright, P. F. (2003) · PubMed · Cited by 74
Contributions of the Avian Influenza Virus HA, NA, and M2 Surface Proteins to the Induction of Neutralizing Antibodies and Protective Immunity
Nayak, B., Kumar, S., DiNapoli, J. M., et al. (2009) · Journal of Virology · doi:10.1128/jvi.02135-09 · Cited by 72
Prevention of Endemic Icteric Viral Hepatitis by Administration of Immune Serum Gamma Globulin
Conrad, M. E., & Lemon, S. M. (1987) · The Journal of Infectious Diseases · doi:10.1093/infdis/156.1.56 · Cited by 71
Immunogenicity of a Reduced Schedule of Pneumococcal Conjugate Vaccine in Healthy Infants and Correlates of Protection for Serotype 6B in the United Kingdom
Goldblatt, D., Southern, J., Ashton, L., et al. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181c67f04 · Cited by 69
Immunological Correlates for Protection against Intranasal Challenge of Bacillus anthracis Spores Conferred by a Protective Antigen-Based Vaccine in Rabbits
Weiss, S., Kobiler, D., Levy, H., Marcus, H., Pass, A., Rothschild, N., & Altboum, Z. (2005) · Infection and Immunity · doi:10.1128/iai.74.1.394-398.2006 · Cited by 69
Responses to measles immunization in children infected with human immunodeficiency virus
Rudy, B. J., Rutstein, R. M., & Pinto‐Martin, J. A. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70125-3 · Cited by 69
Correlates of Immune Protection and the Development of a Human Immunodeficiency Virus Vaccine
Letvin, N. L. (2007) · Immunity · doi:10.1016/j.immuni.2007.09.001 · Cited by 67
Vaccination against the major infectious diseases
Plotkina, S. A. (1999) · Comptes Rendus de l Académie des Sciences - Series III - Sciences de la Vie · doi:10.1016/s0764-4469(00)87191-7 · Cited by 67
Six Years' Follow-up after Hepatitis A Vaccination
Werzberger, A., Kuter, B. J., & Nalin, D. R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804163381615 · Cited by 64
Generating memory with vaccination
Castellino, F., Galli, G., Giudice, G. D., & Rappuoli, R. (2009) · European Journal of Immunology · doi:10.1002/eji.200939550 · Cited by 64
Protection provided by hepatitis B vaccine in a Yupik Eskimo population. Seven-year results
Wainwright, R. B. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.151.8.1634 · Cited by 63
Francisella tularensisInfection-Derived Monoclonal Antibodies Provide Detection, Protection, and Therapy
Savitt, A. G., Mena-Taboada, P., Monsalve, G., et al. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00362-08 · Cited by 62
Serum Levels of Rubella Virus Antibodies Indicating Immunity: Response to Vaccination of Subjects with Low or Undetectable Antibody Concentrations
Matter, L., Kogelschatz, K., & Germann, D. (1997) · The Journal of Infectious Diseases · doi:10.1086/513967 · Cited by 62
Correlating immunity with protection for HPV infection
Frazer, I. H. (2007) · International Journal of Infectious Diseases · doi:10.1016/s1201-9712(07)60016-2 · Cited by 60
Challenges in the evaluation and licensing of new pneumococcal vaccines, 7–8 July 2008, Ottawa, Canada
Feavers, I. M., Knežević, I., Powell, M. M., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.087 · Cited by 60
In Vitro and In Vivo Characterization of Anthrax Anti-Protective Antigen and Anti-Lethal Factor Monoclonal Antibodies after Passive Transfer in a Mouse Lethal Toxin Challenge Model To Define Correlates of Immunity
Staats, H. F., Alam, S. M., Scearce, R. M., et al. (2007) · Infection and Immunity · doi:10.1128/iai.00529-07 · Cited by 60
Detection of memory B lymphocytes specific to hepatitis B virus (HBV) surface antigen (HBsAg) from HBsAg-vaccinated or HBV-immunized subjects by ELISPOT assay
Tuaillon, É., Tabaa, Y. A., Petitjean, G., Huguet, M., Pajeaux, G., Fondere, J.-M., Ponseille, B., Ducos, J., Blanc, P., & Vendrell, J. P. (2006) · Journal of Immunological Methods · doi:10.1016/j.jim.2006.07.016 · Cited by 58
Immunological correlates of protection from HIV infection and disease
Heeney, J. L., & Plotkin, S. A. (2006) · Nature Immunology · doi:10.1038/ni1206-1281 · Cited by 57
Self-citation
Safety and characterization of the immune response engendered by two combined measles, mumps and rubella vaccines
Schwarzer, S., Reibel, S., Lang, A. B., et al. (1998) · Vaccine · doi:10.1016/s0264-410x(97)00174-6 · Cited by 56
Efficacy of Recombinant Bacille Calmette‐Guérin Vaccine Secreting Interleukin‐15/Antigen 85B Fusion Protein in Providing Protection againstMycobacterium tuberculosis
Tang, C., Yamada, H., Shibata, K., Maeda, N., Yoshida, S., Wajjwalku, W., Ohara, N., Yamada, T., Kinoshita, T., & Yoshikai, Y. (2008) · The Journal of Infectious Diseases · doi:10.1086/586902 · Cited by 55
Long-Term Follow-up for Immunity After Monovalent or Combined Live Measles, Mumps, and Rubella Virus Vaccines
Weibel, R. E., Buynak, E. B., McLean, A. A., & Hilleman, M. R. (1975) · PEDIATRICS · doi:10.1542/peds.56.3.380 · Cited by 54
Decline of measles antibody titers after immunization in human immunodeficiency virus-infected children.
Al-Attar, I., Reisman, J. J., Muehlmann, M., et al. (1995) · PubMed · Cited by 52
A high degree of natural immunologic priming to the capsular polysaccharide may not prevent Haemophilus influenzae type b meningitis
Anderson, P. W., Ingram, D. L., Pichichero, M. E., & Peter, G. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200007000-00001 · Cited by 51
Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia
Saaka, M., Okoko, B. J., Kohberger, R. C., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.04.066 · Cited by 51
Increased mumps incidence in the Netherlands: Review on the possible role of vaccine strain and genotype
Kaaijk, P., van der Zeijst, B. A. M., Boog, M. C. J. P., et al. (2008) · Eurosurveillance · doi:10.2807/ese.13.26.18914-en · Cited by 49
DECLINE OF MEASLES ANTIBODY TITERS AFTER IMMUNIZATION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN
&NA; (1995) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199502000-00013 · Cited by 47
Antibodies protect mice against challenge with tick-borne encephalitis virus (TBEV)-infected macrophages
Kreil, T. R., Burger, I., Bachmann, M. P., et al. (1997) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1997.4311446.x · Cited by 45
Cell mediated and antibody immune response to inactivated hepatitis A vaccine
Schmidtke, P., Habermehl, P., Knuf, M., Meyer, C. U., Sänger, R., & Zepp, F. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.06.022 · Cited by 45
[Estimation of the efficacy of three strains of mumps vaccines during an epidemic of mumps in the Geneva canton (Switzerland)].
Chamot, E., Toscani, L., Egger, P., et al. (1998) · PubMed · Cited by 44
Passive immunization against hepatitis A
Stapleton, J. T. (1992) · Vaccine · doi:10.1016/0264-410x(92)90541-q · Cited by 43
Immunity to Mumps in an Institutional Epidemic. Correlation of Insusceptibility to Mumps with Serum Plaque Neutralizing and Hemagglutination-inhibiting Antibodies
Ennis, F. A. (1969) · The Journal of Infectious Diseases · doi:10.1093/infdis/119.6.654 · Cited by 43
The serological assessment of a tetanus toxoid field trial.
Newell, K. W., Leblanc, D., Edsall, G., et al. (1971) · PubMed · Cited by 41
Short‐term immunoglobulin A B‐cell memory resides in intestinal lymphoid tissues but not in bone marrow of gnotobiotic pigs inoculated with Wa human rotavirus
Yuan, L., Geyer, A., & Saif, L. J. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01229.x · Cited by 41
Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis
Sebastian, S., Pinkham, J. T., Lynch, J. G., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.10.079 · Cited by 41
CD4+ T cells control measles virus infection of the central nervous system.
Reich, A., Erlwein, O. W., Niewiesk, S., et al. (1992) · PubMed · Cited by 40
Host, viral, and vaccine factors that determine protective efficacy induced by rotavirus and virus-like particles (VLPs)
Blutt, S. E., Warfield, K. L., O’Neal, C. M., et al. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.08.090 · Cited by 39
The role of CD8+ T cells in immunity to tuberculosis infection
Orme, I. M. (1993) · Trends in Microbiology · doi:10.1016/0966-842x(93)90109-5 · Cited by 38
Imperfect memory and the development of Haemophilus influenzae type b disease
Lucas, A. H., & Granoff, D. M. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200103000-00002 · Cited by 37
Memory T-Cell Response to Rotavirus Detected with a Gamma Interferon Enzyme-Linked Immunospot Assay
Kaufhold, R. M., Field, J. A., Caulfield, M. J., Wang, S., Joseph, H., Wooters, M. A., Green, T., Clark, H. F., Krah, D. L., & Smith, J. G. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5684-5694.2005 · Cited by 36
The Plaque-Neutralization Test as a Measure of Prior Exposure to Measles Virus
Orenstein, W. A., Albrecht, P. G., Herrmann, K. L., et al. (1987) · The Journal of Infectious Diseases · doi:10.1093/infdis/155.1.146 · Cited by 36
Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague
Zauberman, A., Cohen, S. B., Levy, Y., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.01.033 · Cited by 33
Preexisting Poliovirus‐Specific IgA in the Circulation Correlates with Protection against Virus Excretion in the Elderly
Buisman, A., Abbink, F., Schepp, R. M., Sonsma, J. A. J., Herremans, T., & Kimman, T. G. (2008) · The Journal of Infectious Diseases · doi:10.1086/527487 · Cited by 32
Recombinant DNA Hepatitis B Vaccination in Teenagers: Effect of a Booster at 51/2 Years
Milne, A., & Waldon, J. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/166.4.942 · Cited by 32
On the cross-fertilization between biotechnology and immunology: current situation in Cuba
Lage, A. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.101 · Cited by 29
IFN-γ Is the Only Anti-rotavirus Cytokine Found after In Vitro Stimulation of Memory CD4 + T Cells from Mice Immunized with a Chimeric VP6 Protein
McNeal, M., Stone, S. C., Basu, M., Clements, J. D., Choi, A. H.-C., & Ward, R. L. (2007) · Viral Immunology · doi:10.1089/vim.2007.0055 · Cited by 28
Neonatal Tetanus despite Immunization and Protective Antitoxin Antibody
de Moraes‐Pinto, M. I., Oruamabo, R. S., Fp, I., et al. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.4.1076 · Cited by 28
Cell-Mediated Immune Responsiveness to Measles
Gallagher, M. R. (1981) · American journal of diseases of children · doi:10.1001/archpedi.1981.02130250036012 · Cited by 27
Measles Virus-Specific CD4 T-Cell Activity Does Not Correlate with Protection against Lung Infection or Viral Clearance
Pueschel, K., Tietz, A., Carsillo, M., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00160-07 · Cited by 26
Developing an improved vaccine against tuberculosis
McShane, H. (2004) · Expert Review of Vaccines · doi:10.1586/14760584.3.3.299 · Cited by 26
[Antitetanus antibodies. Assay before anatoxinotherapy in 64 tetanus patients].
Goulon, M., Girard, O., Grosbuis, S., et al. (1972) · PubMed · Cited by 26
Sindbis Virus-Based Measles DNA Vaccines Protect Cotton Rats against Respiratory Measles: Relevance of Antibodies, Mucosal and Systemic Antibody-Secreting Cells, Memory B Cells, and Th1-Type Cytokines as Correlates of Immunity
Pasetti, M. F., Ramírez, K., Reséndiz‐Albor, A. A., et al. (2009) · Journal of Virology · doi:10.1128/jvi.02191-08 · Cited by 24
Essential criteria for evaluation of pneumococcal conjugate vaccine candidates
Paradiso, P. R. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.008 · Cited by 23
Generalized Tetanus Despite Prior Vaccination and a Protective Level of Anti-Tetanus Antibodies
Livorsi, D. J., Eaton, M. E., & Glass, J. D. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181c2f534 · Cited by 22
Loss of Varicella Zoster Virus Antibodies Despite Detectable Cell Mediated Immunity after Vaccination
Ludwig, B., Kraus, F. B., Allwinn, R., et al. (2006) · Infection · doi:10.1007/s15010-006-5616-9 · Cited by 21
Correlation Between Rubella Antibody Levels and Cytokine Measures of Cell-Mediated Immunity
Tosh, P. K., Kennedy, R. B., Vierkant, R. A., Jacobson, R. M., & Poland, G. A. (2009) · Viral Immunology · doi:10.1089/vim.2009.0068 · Cited by 21
Development, Acceptance, and Use of Immunologic Correlates of Protection in Monitoring the Effectiveness of Combination Vaccines
Edwards, K. M. (2001) · Clinical Infectious Diseases · doi:10.1086/322562 · Cited by 19
Differential Requirements for T Cells in Viruslike Particle- and Rotavirus-Induced Protective Immunity
Blutt, S. E., Warfield, K. L., Estes, M. K., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01727-07 · Cited by 19
Progressive Immunodeficiency Due to Infection with Human Immunodeficiency Virus Does Not Lead to Waning Immunity to Measles in a Cohort of Homosexual Men
Zolopa, A. R., Kemper, C. A., SHIBOSKI, S. C., et al. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.4.636 · Cited by 18
Response to hepatitis B immunization in children with hemophilia: Relationship to infection with human immunodeficiency virus type 1
Chan, W., Petric, M., Wang, E., et al. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81086-8 · Cited by 12
Sang Froid in a time of trouble: is a vaccine against HIV possible?
Plotkin, S. A. (2009) · Journal of the International AIDS Society · doi:10.1186/1758-2652-12-2 · Cited by 10
Self-citation
Varicella vaccine revisited
LaRussa, P. S., Steinberg, S. P., Shapiro, E. D., et al. (2000) · Nature Medicine · doi:10.1038/82070 · Cited by 9

Research works printed but not linked: 7

Bizzini, B. 1984. Tetanus, p. 37-68. In R. Germanier (ed.), Bacterial vaccines. Harcourt Brace Jovanovich, New York, NY.
LaRussa, P., S. P. Steinberg, E. Shapiro, M. Vazquez, and A. A. Gershon. 2000. Varicella vaccine revisited. Nat. Med.6:1299-1300. · DOI
Abstr. 43rd Intersci. Conf. Antimicrob. Agents Chemother 2003
Plotkin, S. A., and S. E. Reef. 2008. Rubella vaccines, p. 735-771. In S. A. Plotkin, W. A. Orenstein, and P. A. Offit (ed.), Vaccines, 5th ed. Elsevier-Saunders, Philadelphia, PA.
Abstr. 48th Intersci. Conf. Antimicrob. Agents Chemother 2008
Sutter, R. W., and S. L. Cochi. 2008. Live attenuated poliovirus vaccine, p. 631-686. In S. A. Plotkin, W. A. Orenstein, and P. A. Offit (ed.), Vaccines, 5th ed. Elsevier-Saunders, Phildalphia, PA.
WHO. 2007. Rabies vaccines. Wkly. Epidemiol. Rec.82:425-435.

Sorted by citations

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
Rydyznski Moderbacher, C., Ramirez, S. I., Dan, J. M., Grifoni, A., Hastie, K. M., Weiskopf, D., Belanger, S., Abbott, R. K., Kim, C., Choi, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.038 · Cited by 1,790
“The vast majority of licensed human vaccines work on the basis of protective antibody responses, with neutralizing antibodies being the most common mechanism of action (Piot et al., 2019; Plotkin, 2010; Plotkin et al., 2018).”
Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals
Robbiani, D. F., Gaebler, C., Muecksch, F., Lorenzi, J. C. C., Wang, Z., Cho, A., Agudelo, M., Barnes, C. O., Gazumyan, A., Finkin, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2456-9 · Cited by 1,853
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
Anderson, E. J., Rouphael, N. G., Widge, A. T., Jackson, L. A., Roberts, P. C., Makhene, M., Chappell, J. D., Denison, M. R., Stevens, L. J., Pruijssers, A. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2028436 · Cited by 1,523
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J. C., Muecksch, F., Rutkowska, M., Hoffmann, H.-H., Michailidis, E., et al. (2020) · eLife · doi:10.7554/elife.61312 · Cited by 1,308
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
Wajnberg, A., Amanat, F., Firpo, A., Altman, D. R., Bailey, M. J., Mansour, M., McMahon, M., Meade, P., Mendu, D. R., Muellers, K., et al. (2020) · Science · doi:10.1126/science.abd7728 · Cited by 1,195

See all 1,745

Authors: Plotkin, S. A.
Affiliations: University of Pennsylvania (US)
Corresponding author: Plotkin, Stanley A.
ORCID: Plotkin, Stanley A.
Venue: Clinical and Vaccine Immunology
Publisher: American Society for Microbiology
Published: 2010-07
Volume: 17
Issue: 7
Pages: 1055-1065
ISSN: 1556-679X (ISSN-L)
1556-6811
DOI: 10.1128/cvi.00131-10
PMC: PMC2897268
OpenAlex: W2160358721
Cited by: 1,745
References: 204
Citations by year: 2026: 128 · 2025: 123 · 2024: 121 · 2023: 139 · 2022: 155 · 2021: 183 · 2020: 137 · 2019: 120 · 2018: 94 · 2017: 101 · 2016: 77 · 2015: 96 · 2014: 75 · 2013: 81 · 2012: 61
FWCI: 4.99
Type: journal article
Language: en
Open access: diamond
doi.org
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Clinical and Vaccine Immunology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords: correlates of protection, vaccine response, antibody function, mucosal antibodies, immunological memory, effector memory T cells, central memory T cells, cell-mediated immunity, intracellular pathogens, antibody synergy, surrogate markers
MeSH terms: Antibodies, Humans, Immunity, Immunity, Cellular, Immunologic Memory, Vaccines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Correlates of Protection Induced by Vaccination

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks